18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR2400081879
尚未开始
/
/
/
2024-03-14
/
/
Anxiety, depression
The mediating role of cognitive fusion, experiential avoidance, and low self-esteem in self-critical perfectionism and depression/anxiety: A randomized controlled trial on ACT-based program
The mediating role of cognitive fusion, experiential avoidance, and low self-esteem in self-critical perfectionism and depression/anxiety: A randomized controlled trial on ACT-based program
Study 1: - Provide a model to the existing understanding of the relationship between self-critical perfectionism and depression/anxiety as well as the underlying mechanisms. - Identify prominent factors such that intervention can be developed to mitigate self-critical perfectionists from developing depression/anxiety. Study 2: - Test the efficacy of Acceptance and Commitment Therapy (ACT) as a low-intensity early intervention for those at risk for depression and anxiety. - Conduct a focus group analysis on those high in self-critical perfectionism. - Examine the impact of therapeutic alliance on treatment effect. - Test the model as proposed in Study 1 with this longitudinal data.
随机平行对照
其它
A research staff who is blinded to the study's design will randomly allocate the list of enrolled participants to either condition 1 (treatment group) or condition 2 (waitlist control) using Excel.
None
/
/
420;84
/
2023-12-01
2025-12-31
/
Study 1: Adults aged 18 or above. Study 2: Adults aged 18-65; people with at least mild level of depression or anxiety;
登录查看Study 1: None Study 2: People with serious mental disorder; people with suicidal attempt within the past 6 months or scored 2 or above on item 9 of Patient Health Questionnaire (PHQ-9); people with active psychotic symptoms; people receiving active psychological intervention;
登录查看University of Hong Kong
/
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16
药明康德2025-01-16
再鼎医药2025-01-16
Rimonci2025-01-15